Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis. Mattoscio M, Nicholas R, Sormani MP, Malik O, Lee JS, Waldman AD, Dazzi F, Muraro PA Neurology. 2015 Mar 11. PMID: 25762712. Abstract CommentRecommendBookmarkWatch